期刊文献+

晚期糖基化终产物对脂肪细胞产生活性氧的诱导作用及其机制 被引量:2

Advanced glycosylation end products induce production of reactive oxygen species in adipocytes and the mechanism
下载PDF
导出
摘要 目的观察晚期糖基化终产物(AGEs)对脂肪细胞产生活性氧(ROS)的影响及机制。方法 3T3-L1前脂肪细胞体外培养并诱导分化为成熟的脂肪细胞,以小鼠血清白蛋白(MSA)作为阴性对照,用不同浓度(25、50、100μg/mL)AGEs共同孵育不同时间(0、5、15、30 min及1、3 h)后,荧光探针2',7'-二氯荧光素乙二酯测定细胞ROS生成水平,间接反映ROS的产生量。分别应用酶特异性抑制剂预处理脂肪细胞,观察AGEs-MSA刺激脂肪细胞生成ROS的变化。结果 AGEs能诱导脂肪细胞产生ROS,ROS的产生量随MSA氧化程度的升高和AGEs-MSA浓度的增加而增多。AGEs诱导脂肪细胞产生的超氧阴离子能被NADPH氧化酶的阻断剂DPI和apocynin明显抑制,不能被其他酶的阻断剂所抑制。结论 AGEs能够诱导脂肪细胞产生ROS,其部分机制可能与NADPH氧化酶激活有关。 Objective To investigate the mechanism of advanced glycosylafion end products (AGEs) inducing the production of reactive oxygen species (ROS) in adipocytes. Methods The 3T3 - L1 adipocytes were cultured and differentiated into mature adipocytes in vitro. Cultured adipocytes were incubated with indicated concentrations (25, 50 and 100 fxg/mL) of AGEs - modified murine serum albumin (MSA) for 1 h, or treated with 100 mg/mL of AGEs - MSA for the indicated durations (0, 5, 15, 30, 60 and 180 min). The production of ROS was determined by fluorescence probe DCFHDA. To clarify the underlying mechanism of AGEs - induced ROS production, adipocytes were preincubated for 1 h with the inhibitors of various enzymatic systems involved in ROS generation. The changes of ROS production were detected. Results Compared with cells incubated with medium alone or native MSA, AGEs - MSA induced ROS production in adipocytes in time - and dose - dependent manners, and the quantity of ROS increased with the oxidation degree of MSA. The AGEs -triggered ROS generation was significantly suppressed by pretreatment with apocynin and DPI, the inhibitors of NADPH oxidase; but not the other inhibitors. Conclusion AGEs - MSA induces ROS production in adipocytes, partially mediated by NADPH oxidase activation.
出处 《广东医学》 CAS CSCD 北大核心 2014年第1期39-42,共4页 Guangdong Medical Journal
基金 广东省医学科研基金资助项目(编号:B2012244) 南方医科大学青年科技人员培育项目(编号:201201547) 南方医科大学第三附属医院院长基金资助项目(编号:B20111109)
关键词 晚期糖基化终产物 活性氧 NADPH氧化酶 脂肪细胞 advanced glycation end products reactive oxygen species NADPH oxidase adipocytes
  • 相关文献

参考文献15

  • 1LEE J E, CHOI S Y, HUH W, et al. Metabolic syndrome, C - reactive protein, and chronic kidney disease in nondiabetic, nonby pertensive adults [ J ]. Am J Hypertens, 2007, 20 ( 11 ) : 1189 - 1194,.
  • 2HOTAMISLIGIL G S. Inflammation and metabolic disorders [ J 1. Nature, 2006, 444(7121 ) : 860 -867.
  • 3GRUNDY S M. Atherosclerosis imaging and the futm of lipid management [ J 1. Circulation, 2004, 110 (23) : 3509 - 3511.
  • 4ROYTMLAT L, RACHINSKY M, FISHER A, et al. Raised inter- leukin - 6 levels in obese patients [ J ]. Obes Res, 2000, 8 (9) : 673 - 675.
  • 5YAMAGISHI S, MATSUI T. Advanced glycation end products (AGEs), oxidative stress and diabetic retinopathy [ J 1. Curr Pharm Biotechnol, 2011, 12(3) : 362 -368.
  • 6SHI H, SHI X, LIU K J. Oxidative mechanism of arsenic toxicity and carcinogenesis [ J ]. Mol Cell Biochem, 2004, 255 ( 1/2 ) : 67 -78.
  • 7HOU F F, BOYCE J, CHERTOW G W, et al. Aminoguanidine inhibites advanced glycation end products formation on beta 2 - mi- croglobulin[J]. J Am Soc Nephrol, 1998, 9(2) : 277 -283.
  • 8SU J, LUCCHESI P A, GONZALEZ VILLALOBOS R A, et al. Role of advanced glycation end products with oxidative stress in re- sistance artery dysfunction in type2 diabetic mice[J]. Arterioscler Thromb Vasc Biol, 2008, 28(8) : 1432 -1438.
  • 9TANG J, YAN H, ZHUANG S. Inflammation and oxidative stress in obesity - related glomerulopathy [ J ]. Int J Nephrol, 2012, 2012: 1-11.
  • 10. YAMAGISHI S, MAEDA S, MATSUI T, et al. Role of advanced glycation end products (AGEs) and oxidative stress in vascular complications in diabetes[ 3. Biochim Biophys Acta, 2011 , 1'820 (5) : 663 -67l.

二级参考文献31

  • 1杨小兵,侯凡凡,武强,周华,刘郑荣,杨燕,张训.慢性肾脏病患者晚期氧化蛋白产物血症及其与动脉粥样硬化的关系[J].中华内科杂志,2005,44(5):342-346. 被引量:41
  • 2Liu SX, Hou FF, Guo ZJ, et al. Advanced oxidation protein products accelerate atherosclerosis through promoting oxidative stress and inflammation. Arterioscler Thromb Vasc Biol, 2006, 26: 1156-1162.
  • 3Li HY, Hou FF, Zhang X, et al. Advanced oxidation protein products accelerate renal fibrosis in a remnant kidney model. J Am Soe Nephrol, 2007, 18: 528-538.
  • 4Shi XY, Hou FF, Niu HX, et al. Advanced oxidation protein products promote inflammation in diabetic kidney through activation of renal nicotinamide adenine dinucleotide phosphate oxidase. Endocrinology, 2008, 149: 1829-1839.
  • 5He LJ, Liang M, Hou FF, et al. Ethanol extraction of Picrorhiza scrophulariiflora prevents renal injury in experimental diabetes via anti-inflammation action. J Endocrinol, 2009, 200 : 347-355.
  • 6Guo Z J, Hou FF, Liu SX, et al. Picrorhiza scrophulariiflora improves accelerated athemsclerosis through inhibition of redoxsensitive inflammation. Int J Cardiol, 2009, in press, doi: 10. 1016/j. ijcard. 2008.12. 102.
  • 7Collins A J, Couser WG, Dirks JH, et al. World Kidney Day: an idea whose time has come. Kidney Int, 2006, 69:781-782.
  • 8Li ZY, Xu GB, Xia TA, et al. Prevalence of chronic kidney disease in a middle and old-aged population of Beijing. Clin Chim Acta, 2006, 366: 209-215.
  • 9Eddy AA, Molecular insights into renal interstitial fibrosis. J Am Soc Nephrol, 1996, 7: 2495-2508.
  • 10Schieppati A, Remuzzi G. The June 2003 Barry M. Brenner Comgan lecture. The future of renoprotection: frustration and promises. Kidney Int, 2003, 64:1947-1955.

共引文献2

同被引文献30

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部